Diabetes Care Expansion Orpyx is expanding its sensory insole platform and remote care solutions to prevent diabetic foot ulcers, signaling outbound sales opportunities with healthcare providers, clinics, and systems focused on diabetes management and complication prevention.

Growth Funding Momentum Recent $20M growth capital funding led by Perceptive Advisors and ongoing investor interest indicate readiness for scaled deployments and commercial partnerships, making enterprise deals with hospitals, clinics, and payers more viable.

Remote Monitoring Strength A credentialed remote patient monitoring team and data-driven clinical escalation framework present opportunities to partner with health systems emphasizing telehealth, remote monitoring programs, and chronic disease management integration.

North America Reach Expansion beyond Calgary to Edmonton and a strong Canadian footprint, plus potential U.S. market interest, open doors for regional health networks, distributors, and strategic alliances in North America.

Diabetes Economics Public attention to the costly burden of diabetic foot complications, including multi-billion impact, creates a compelling value case for payers and providers to adopt preventive insoles and associated remote care solutions.